Baker McKenzie advises Main Capital Partners on the acquisition of a majority stake in IQ Messenger, a leading provider of a vendor-neutral critical communication platform for healthcare institutions.
As detailed in Main Capital Partners’ press release, “this partnership represents a significant milestone in IQM’s growth journey. Main will help IQM drive continued innovation to create customer value for its customers, while maintaining a strong emphasis on customer satisfaction. Additionally, Main will support an ambitious strategy to accelerate (international) expansion through both organic growth and a targeted buy-and-build approach.”
The healthcare software market is one of Main’s core product-markets, supported by deep sector expertise through prior and current investments. IQM is well positioned to capitalize on key market trends such as the growing need for more sophisticated out-of-hospital care, the demand for integrated and interoperable platforms, and the increasing importance of secure communication in healthcare.
The cross-border, multidisciplinary Baker McKenzie team advising Main Capital Partners was led by Amsterdam Private Equity partners Mo Almarini and Joost Polman, supported by Laila Kouchi, Daan Paquay, Koen Bos, Thijs Bogaers, Vera van Blerck, Rafi Salhi, Paul Goedvolk, Kathinka Driessen, Fréderique Hubbelmeijer, Roderick Beudeker, Loïs Knijpinga, Cornelien Broersma, Benjamin van Kessel, Nathalja Doing, Joost Lichtendahl, Eva Sluijmer, Romy van ’t Veer, Stephan Huis in het Veld, Mijke Patijn, Fleur Linssen, and Frans Muller. The team also included Olha Sviatenka and Els Janssens (Baker McKenzie Belgium), Alla Smorodyna (Baker McKenzie Ukraine), and Matthew Berridge, Jonathan Sharp and Emma Holder (Baker McKenzie London).
As detailed in Main Capital Partners’ press release, “this partnership represents a significant milestone in IQM’s growth journey. Main will help IQM drive continued innovation to create customer value for its customers, while maintaining a strong emphasis on customer satisfaction. Additionally, Main will support an ambitious strategy to accelerate (international) expansion through both organic growth and a targeted buy-and-build approach.”
The healthcare software market is one of Main’s core product-markets, supported by deep sector expertise through prior and current investments. IQM is well positioned to capitalize on key market trends such as the growing need for more sophisticated out-of-hospital care, the demand for integrated and interoperable platforms, and the increasing importance of secure communication in healthcare.
The cross-border, multidisciplinary Baker McKenzie team advising Main Capital Partners was led by Amsterdam Private Equity partners Mo Almarini and Joost Polman, supported by Laila Kouchi, Daan Paquay, Koen Bos, Thijs Bogaers, Vera van Blerck, Rafi Salhi, Paul Goedvolk, Kathinka Driessen, Fréderique Hubbelmeijer, Roderick Beudeker, Loïs Knijpinga, Cornelien Broersma, Benjamin van Kessel, Nathalja Doing, Joost Lichtendahl, Eva Sluijmer, Romy van ’t Veer, Stephan Huis in het Veld, Mijke Patijn, Fleur Linssen, and Frans Muller. The team also included Olha Sviatenka and Els Janssens (Baker McKenzie Belgium), Alla Smorodyna (Baker McKenzie Ukraine), and Matthew Berridge, Jonathan Sharp and Emma Holder (Baker McKenzie London).
Explore Our Newsroom